IQVIA HOLDINGS INC. Derivative Liability, Fair Value, Amount Not Offset Against Collateral
IQVIA HOLDINGS INC. (IQV) had Derivative Liability, Fair Value, Amount Not Offset Against Collateral of $293.00 million as of 2026-03-31, per its 10-Q filed 2026-05-05.
Financial Statements › Notes › Offsetting
us-gaap:DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral · last filed 2026-05-05
- 2026-03-31: Derivative Liability, Fair Value, Amount Not Offset Against Collateral $293.00M.
- 2025-12-31: Derivative Liability, Fair Value, Amount Not Offset Against Collateral $367.00M.
- 2025-09-30: Derivative Liability, Fair Value, Amount Not Offset Against Collateral $391.00M.
- 2025-06-30: Derivative Liability, Fair Value, Amount Not Offset Against Collateral $406.00M.
| Period end | Derivative Liability, Fair Value, Amount Not Offset Against Collateral |
|---|---|
| 2026-03-31 | $293.00M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $367.00M 10-Q · filed 2026-05-05 |
| 2025-09-30 | $391.00M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $406.00M 10-Q · filed 2025-07-22 |
| 2025-03-31 | $125.00M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $7.00M 10-K · filed 2026-02-17 |
| 2024-09-30 | $172.00M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $10.00M 10-Q · filed 2024-07-22 |
| 2024-03-31 | $70.00M 10-Q · filed 2024-05-02 |
| 2023-12-31 | $159.00M 10-K · filed 2025-02-13 |
| 2023-09-30 | $4.00M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-01 |
| 2023-03-31 | $7.00M 10-Q · filed 2023-04-28 |
| 2022-12-31 | $2.00M 10-K · filed 2024-02-15 |
| 2022-09-30 | $15.00M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $10.00M 10-Q · filed 2022-07-22 |
| 2022-03-31 | $10.00M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $27.00M 10-K · filed 2023-02-15 |
| 2021-09-30 | $42.00M 10-Q · filed 2021-10-22 |
| 2021-06-30 | $42.00M 10-Q · filed 2021-07-28 |
| 2021-03-31 | $44.00M 10-Q · filed 2021-04-23 |
| 2020-12-31 | $56.00M 10-K · filed 2022-02-16 |
| 2020-09-30 | $61.00M 10-Q · filed 2020-10-22 |
| 2020-06-30 | $65.00M 10-Q · filed 2020-07-23 |
| 2020-03-31 | $55.00M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $30.00M 10-K · filed 2021-02-12 |
| 2019-09-30 | $40.00M 10-Q · filed 2019-11-01 |
| 2019-06-30 | $36.00M 10-Q · filed 2019-07-24 |
| 2019-03-31 | $22.00M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $17.00M 10-K · filed 2020-02-18 |
| 2018-09-30 | $10.00M 10-Q · filed 2018-10-25 |
| 2018-06-30 | $10.00M 10-Q · filed 2018-07-27 |
| 2018-03-31 | $13.00M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $13.00M 10-K · filed 2019-02-19 |
| 2017-09-30 | $19.00M 10-Q · filed 2017-10-27 |
| 2017-06-30 | $19.00M 10-Q · filed 2017-08-04 |
| 2017-03-31 | $15.00M 10-Q · filed 2017-05-08 |
| 2016-12-31 | $25.00M 10-K · filed 2018-02-16 |
| 2015-12-31 | $11.00M 10-K · filed 2017-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |